<?xml version="1.0" encoding="UTF-8"?>
<p id="Par5">Cytokine storm, along with viral evasion of cellular immune responses, may play an equally important role in disease progression. Thus, tackling the immune response with immunomodulatory agents may be as important as addressing viral replication to prevent the progression to multiorgan dysfunction (Fig. 
 <xref rid="Fig1" ref-type="fig">1</xref>). Herein, we discuss the role of specific and non-specific immunomodulating agents, including neutralizing monoclonal antibodies, corticosteroids, and other molecules in the management of severe COVID-19, and their impact on survival and clinical symptoms.
</p>
